Meeting
2015 Gastrointestinal Cancers Symposium
Defining the optimal timing of adjuvant therapy for resected pancreatic cancer: A statewide cancer registry analysis.
Authors
Hayder M. Saeed
University of Kentucky, Lexington, KY
Hayder M. Saeed , Dima Hnoosh , Bin Huang , Eric B Durbin , Patrick McGrath , Erin Maynard , Mahesh R. Kudrimoti , Lowell Brian Anthony , Peter Joel Hosein , Philip A. DeSimone , Ching-Wei David Tzeng
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 406)
DOI
10.1200/jco.2015.33.3_suppl.406
Abstract #
406
Poster Bd #
D25
Abstract Disclosures
Similar Posters
Poster
2015 Gastrointestinal Cancers Symposium
Adjuvant therapy (Adj) in intraductal papillary mucinous neoplasm cancer (IPMN-Ca) versus pancreatic ductal adenocarcinoma (PDAC): Comparison of survival analyses.
First Author: Kavya Krishna
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of the CRM status in pancreatic ductal adenocarcinoma: Data from a regional cancer registry.
First Author: Philipp Morakis
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The prognostic value of mutational signatures in pancreatic cancer.
First Author: Nicholas Light
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe